Tessenderlo Group Releases First Gelatin Bioink in Claro Series

Share this Article

An inclusive team of scientists at Tessenderlo Group, headquartered in Belgium, has announced a recent breakthrough in bioprinting with the creation of new gelatin materials for tissue engineering. Today, they announce the release of their first bio-ink to take its place in the Claro™ series of tissue-engineering products.

ClaroBGI600 has been created by Tessenderlo to combine gelatin and flow, at previously unheard-of levels. As a progressive new bioink, ClaroBGI600 offers the following features:

  • Much greater affordability for companies engaged in bioprinting
  • Proven printing time of up to two hours
  • Eliminates issues with clogging
  • Maintains positive qualities of gelatin during printing, and is highly biocompatible
  • No printability enhancers

“The propriety Claro technology enables printing with lower pressure and excellent shape fidelity, without affecting the biocompatibility and final gel strength of the construct. This makes it the perfect material for 3D printing tissue engineering applications,” states the Tessenderlo Group in their most recent press release.

With headquarters around the globe, Tessenderlo Group employs around 4,600 people, with revenues of $1.6 billion last year. Tessenderlo is a leading industrial company known for their emphasis on progressive agricultural processes and solutions:

“Tessenderlo Group continually strives to find more sustainable solutions. We thereby aim to minimize our ecological footprint and to maximize the contribution of our products in the evolution towards achieving a green economy. We offer various products and environmentally friendly solutions, in which we typically reclaim and transform by-products from other industries,” states Tessenderlo on their website.

“Whether it is in the products and solutions we supply or the way in which we produce them, the care we show towards our planet and its resources is at the very heart of all our businesses. This is because we believe that every molecule counts.”

Meet with Tessenderlo Group scientists to find out more about Claro when they are exhibiting at the Biofabrication & Biomanufacturing Europe 2019 event in Rotterdam, The Netherlands, from June 20-21. Contact the company at flow@claro.science if you would like to set up an appointment to meet with their team. Are you interested in ordering a sample of ClaroBGI600? Find out more here.

There is so much to get excited about in the world of 3D printing as we learn about innovations rocking industry and changing the world. And while much of the thriving 3D printing marketplace revolves around countless choices in shiny new hardware, the realm of materials is vast too—whether you are a user exploring polymers like ABS or PLA, an industrialist branching out with materials like concrete or metal, or a scientist customizing your own tools and composite materials in the lab. Bioprinting has taken off though, evidenced by the massive progress in tissue engineering and the ongoing supply of new bioinks allowing researchers to fabricate implants and more with cell-laden materials.

What do you think of this news? Let us know your thoughts! Join the discussion of this and other 3D printing topics at 3DPrintBoard.com.

[Source / Images: Tessenderlo Group]
Facebook Comments

Share this Article


Related Articles

Interview with Jose Manuel Baena of Regemat 3D and Breca Health Care

Nanjing Medical University: 3D Printing Scaffolds with Lithium for Cartilage Regeneration



Categories

3D Design

3D Printed Art

3D Printed Food

3D Printed Guns


You May Also Like

Interview with Alok Anil of Next Big Innovation Labs

This interview features Alok Medikepura Anil. He has great subject matter expertise within the realms of engineering and policy. His knowledge will give some people insight into how 3D bioprinting is reliant upon policy within the future.

Porous Metallic Biomaterials Rely on Additive Manufacturing Processes for Substitute Bone Regeneration Structures

In ‘Additively manufactured porous metallic biomaterials,’ Amir A. Zadpoor explores porous metallic biomaterials in research for bone tissue regeneration, discussing elements such as design, manufacturing, and bio-functionalization—as well as examining...

Aspect Biosystems Heads $2.2 Million Project with New Microfluidic 3D Bioprinting Platform

Aspect Biosystems, headquartered in Vancouver, has created a new microfluidic 3D bioprinting platform to further the progress of tissue engineering. In a collaboration with Merck, GSK, and McGill University’s Goodman...

Electrospinning Fibers for Better Success in 3D Printing Biomimetic Scaffolds

In ‘Three-dimensional printed electrospun fiber-based scaffold for cartilage regeneration,’ Chinese researchers attempt to improve on processes for creating better materials and customized geometries in bioprinting. Here, they not only employ...


Training


Shop

View our broad assortment of in house and third party products.


Print Services

Subscribe To Our Newsletter

Subscribe To Our Newsletter

Join our mailing list to receive the latest news and updates from our 3DPrint.com.

You have Successfully Subscribed!